244 related articles for article (PubMed ID: 24129063)
1. NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi.
Charbel C; Fontaine RH; Malouf GG; Picard A; Kadlub N; El-Murr N; How-Kit A; Su X; Coulomb-L'Hermine A; Tost J; Mourah S; Aractingi S; Guégan S
J Invest Dermatol; 2014 Apr; 134(4):1067-1074. PubMed ID: 24129063
[TBL] [Abstract][Full Text] [Related]
2. BRAF mutations are also associated with neurocutaneous melanocytosis and large/giant congenital melanocytic nevi.
Salgado CM; Basu D; Nikiforova M; Bauer BS; Johnson D; Rundell V; Grunwaldt LJ; Reyes-Múgica M
Pediatr Dev Pathol; 2015; 18(1):1-9. PubMed ID: 25490715
[TBL] [Abstract][Full Text] [Related]
3. Lack of BRAF(V600E) mutations in giant congenital melanocytic nevi in a Chinese population.
Wu D; Wang M; Wang X; Yin N; Song T; Li H; Yu J; Wang DM; Zhao Z
Am J Dermatopathol; 2011 Jun; 33(4):341-4. PubMed ID: 21430505
[TBL] [Abstract][Full Text] [Related]
4. Genetic Abnormalities in Large to Giant Congenital Nevi: Beyond NRAS Mutations.
Martins da Silva V; Martinez-Barrios E; Tell-Martí G; Dabad M; Carrera C; Aguilera P; Brualla D; Esteve-Codina A; Vicente A; Puig S; Puig-Butillé JA; Malvehy J
J Invest Dermatol; 2019 Apr; 139(4):900-908. PubMed ID: 30359577
[TBL] [Abstract][Full Text] [Related]
5. BRAF, NRAS, and GNAQ Mutations in Conjunctival Melanocytic Nevi.
Francis JH; Grossniklaus HE; Habib LA; Marr B; Abramson DH; Busam KJ
Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):117-121. PubMed ID: 29332123
[TBL] [Abstract][Full Text] [Related]
6. Molecular Genomic Profiling of Melanocytic Nevi.
Colebatch AJ; Ferguson P; Newell F; Kazakoff SH; Witkowski T; Dobrovic A; Johansson PA; Saw RPM; Stretch JR; McArthur GA; Long GV; Thompson JF; Pearson JV; Mann GJ; Hayward NK; Waddell N; Scolyer RA; Wilmott JS
J Invest Dermatol; 2019 Aug; 139(8):1762-1768. PubMed ID: 30772300
[TBL] [Abstract][Full Text] [Related]
7. Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS.
Kinsler VA; Thomas AC; Ishida M; Bulstrode NW; Loughlin S; Hing S; Chalker J; McKenzie K; Abu-Amero S; Slater O; Chanudet E; Palmer R; Morrogh D; Stanier P; Healy E; Sebire NJ; Moore GE
J Invest Dermatol; 2013 Sep; 133(9):2229-36. PubMed ID: 23392294
[TBL] [Abstract][Full Text] [Related]
8. NRAS and BRAF mutations in melanoma-associated nevi and uninvolved nevi.
Tschandl P; Berghoff AS; Preusser M; Burgstaller-Muehlbacher S; Pehamberger H; Okamoto I; Kittler H
PLoS One; 2013; 8(7):e69639. PubMed ID: 23861977
[TBL] [Abstract][Full Text] [Related]
9. Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations.
Bauer J; Curtin JA; Pinkel D; Bastian BC
J Invest Dermatol; 2007 Jan; 127(1):179-82. PubMed ID: 16888631
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic mutations in melanomas and benign melanocytic nevi of the female genital tract.
Tseng D; Kim J; Warrick A; Nelson D; Pukay M; Beadling C; Heinrich M; Selim MA; Corless CL; Nelson K
J Am Acad Dermatol; 2014 Aug; 71(2):229-36. PubMed ID: 24842760
[TBL] [Abstract][Full Text] [Related]
11. Aggressive melanoma in an infant with congenital melanocytic nevus syndrome and multiple, NRAS and BRAF mutation-negative nodules.
de la Rosa Carrillo D; Vindenes H; Kinsler VA; Rønnestad A; Ringstad G; Müller LO; Tafjord S; Tønseth KA; Kvamme B; Clausen OPF
Pediatr Dermatol; 2018 Sep; 35(5):e281-e285. PubMed ID: 29999207
[TBL] [Abstract][Full Text] [Related]
12. Hiding in plain sight: molecular genetics applied to giant congenital melanocytic nevi.
Etchevers HC
J Invest Dermatol; 2014 Apr; 134(4):879-882. PubMed ID: 24646799
[TBL] [Abstract][Full Text] [Related]
13. Spatiotemporal expression of NRAS and occurrence of giant congenital melanocytic nevi.
Aimaier R; Chung M; Zhu H; Yu Q
Exp Dermatol; 2022 Apr; 31(4):582-585. PubMed ID: 35020224
[TBL] [Abstract][Full Text] [Related]
14. BRAF and NRAS mutations in melanoma and melanocytic nevi.
Poynter JN; Elder JT; Fullen DR; Nair RP; Soengas MS; Johnson TM; Redman B; Thomas NE; Gruber SB
Melanoma Res; 2006 Aug; 16(4):267-73. PubMed ID: 16845322
[TBL] [Abstract][Full Text] [Related]
15. Acquisition of Somatic NRAS Mutations in Central Nervous System Melanocytes: A Predisposing Risk Factor to Primary Melanoma of the Central Nervous System, a Frequently Forgotten Pitfall in Congenital Nevi.
Garrido MC; Maroñas-Jiménez L; Morales-Raya C; Ruano Y; Rodriguez-Peralto JL
Am J Dermatopathol; 2018 Jul; 40(7):506-510. PubMed ID: 29077579
[TBL] [Abstract][Full Text] [Related]
16. Massively parallel sequencing analysis of benign melanocytic naevi.
Lozada JR; Geyer FC; Selenica P; Brown D; Alemar B; Merghoub T; Berger MF; Busam KJ; Halpern AC; Weigelt B; Reis-Filho JS; Hollmann TJ
Histopathology; 2019 Jul; 75(1):29-38. PubMed ID: 30791119
[TBL] [Abstract][Full Text] [Related]
17. Novel genetic alteration in congenital melanocytic nevus: MAP2K1 germline mutation with BRAF somatic mutation.
Zou Y; Sun Y; Zeng X; Liu Y; Cen Q; Gu H; Lin X; Cai R; Chen H
Hereditas; 2020 Aug; 157(1):35. PubMed ID: 32847629
[TBL] [Abstract][Full Text] [Related]
18. Large-Giant Congenital Melanocytic Nevi: Moving Beyond NRAS Mutations.
Stark MS
J Invest Dermatol; 2019 Apr; 139(4):756-759. PubMed ID: 30904080
[TBL] [Abstract][Full Text] [Related]
19. The BRAF and NRAS mutation prevalence in dermoscopic subtypes of acquired naevi reveals constitutive mitogen-activated protein kinase pathway activation.
Tan JM; Tom LN; Jagirdar K; Lambie D; Schaider H; Sturm RA; Soyer HP; Stark MS
Br J Dermatol; 2018 Jan; 178(1):191-197. PubMed ID: 28714107
[TBL] [Abstract][Full Text] [Related]
20. The retrospective molecular analysis of large or giant congenital melanocytic nevi in a group of Polish children.
Wertheim-Tysarowska K; Szczygielski O; Seliga K; Tysarowski A; Bal J; Michalak E; Rygiel AM; Sawicka E
J Mother Child; 2021 Oct; 25(1):19-24. PubMed ID: 34643354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]